ML20135G654
| ML20135G654 | |
| Person / Time | |
|---|---|
| Site: | McGuire, Mcguire  |
| Issue date: | 06/30/1985 |
| From: | Tucker H DUKE POWER CO. |
| To: | Grace J NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION II) |
| References | |
| NUDOCS 8509200044 | |
| Download: ML20135G654 (29) | |
Text
. _ _ _. - _ . - -_
t MCEWIM NUCLEM 514 TION i EFFLUENT AW IIAllt DIlp0 SAL SWPLEMNTE IIFOMAllON M PORT M:E: OSINft$
PERIS C88E8E8 STABI M i = H I 510P Mi a 101 i
I. RECEATORT LIMill A. NOBLE Celt 5 - Alt 30M B. LIGUlf EFFLUENil - 00$E I CALEMat GUARTER - Cassie SOM = 5 MMO I CALEmma GU4 ster - TOIR 900T DOSE = 1.5 MeEM
- 2. CRENMe quesTEn - Mit Self a le 1840 E. CALENMA OUaATER - ORCM 905E = $ MER 3 CALEuget TEde - CANNA BOSE
- 10 M AS 3 CALElleet TEM - TOTE BOOT 905E = 3 MRDI
- 4. CREW 48 TEM - MTA 005E = M MBAO 4. CEENDAR TEM - geGM DOSE = le MetM C. 10BINE - 131 ANO ISS, 19111011, PARilCE ATE 5 Ulf lit i O Mil - 08C411 00$E I. CALElleas gudette e T.3 mEM
- 2. CREM548 TEAR e 13flREM II. MAXIMUM PEHil51EE CONCENfM110ll5
- 4. CAHOUS EFFlutull - IweaMilm FOUW IN OFF5ITE 905E CRCULAllON MWAL B. LitWIB EFFLUENil - IWpMATION FOUW IN IOCFGH, APPEWII B, TABLE !!, C8 Lip 412
! !!!. AVE MGE E M AGT - M1 APPLICABLE
- 19. MA5UREMEM15 AND APP 90tlM119NS EF 19f4 R4010ACTIVIfi IWeemil04 Feum IN FF5 lit DOM CRCEATISIl itANUAL i V. BATCH DELEASES A. LISUID EFFLUENT I 5 44El92 = TOTE NUMOER OF SAICN MLE4H5
- 2. 4.4M694 o TOTAL TIMEIMIN.I FOR BATCII RELEAM5.
3 119Ef t3
- MX! MUM TIMIMIN.I FOR & BAIDI RELEAM.
- 4. T IMitt
- HERACE TIMIMIN.I FOR A MTCM MLEAM.
- 3. S ittttt a MIN! MUM !!MEIMIN.I FOR A MTCM MLEA5E.
- 4. T.TM681
- HENGE SILUTIOlt IIATER FL88 OURINE MLEAW5tCPMI.
B. CASEDUS EFFLUENT
- i. 3.tMitt = itTE IIUMBER OF MTCit MLEAM5.
- 2. 5 36EttS = 1974 TIMIMIN.I FOP MICII BELEASES.
i 3. 4 3M604 = M11 MUM IIMIMIN.I FOR A MTCII MLEASE.
4.1.14Ett3 e AVENCE TIMININ.I FOR A BATCil RELEA5E.
i S. f. steth = NINilillll TIMININ.I F08 4 MTOl MLE45E.
- 91. 40McM 4 MLEAM5 A. LitUID
- 1. NUMMR OF MLEAM5 O
- a. TOTAL ACT!vlTT sEtEAHHWHir , 0,,,,,,,,,,,, -
- s. cA$tOU5
- 1. IlUMMR OF MLEAH5 d 0 '
- r. total ACTIslir M LEAM ii W illi-l R
nCCUlRE NUCLEAR STATION
+ MSIGACTIVE EFFLUENT RELEASES r - BATE : 00/12/05
- 1. L1!!IRELE45El TEAR 1995 (RIIT5 15T 013 IN8 OTR luet0TAL
- 1. C8055 R4010ACllttli - 1 A. TOTAL RELEASE CURIE 5 f.9X-t! 4.26E-01 7.ttt-01 '
O. AVERAGE CONCENTN TION MLEA$ED UCIIML 6.34E-10 I !!E it 7.40E 19 C. MIIMUM CONCLNIRATIOlt RELEASED UCllE 3.29E Of 4.3tt 09 4.31[-09
- 2. TRiflUM 4 IDTR MLEASE CURIES 2.!? tit 2 1.04Elst 4.0X402
- 8. AMRAGE CONCENTRefl0N MLEAM O UCIINL 4.91E 01 3. Set-07. 4.15E-07
- 3. Oll5 OLE D N0BLE CASE 5 A. TOIR MLEASE CURIE 5 2.6M ft 1.7M 02 4.35E-82
- 8. HERAGE CONCENTRAi!ON BELEASEB UCIlpL 5.87E Il 3.3M-11 4.40E-11
- 4. CA055 R PNA ACT!ttif A. TOTE RELEASE CURIE 5 S.Ittttt 9.StEtte t 90E609 B. &#E NCE CONCENTNTION RELEASED UCIIE t.tMile 0.tMile 0.etElle S. VOLUME OF LIOUID M5fE TO O!5CHARCE CANAL' lifer $ 7.0 Mile 7.4tEtte 1.44 Eft?
- 4. VOLUME OF O!LU110N UATER LI?!05 4.46 Ell! 3.26Ett! 9.7 Mitt
- 7. RA010ffuCLIDE5 RELEA5ED CURIES PA 24 9 ZIE-OS 2 2M-04 3.16E 04 Ct-31 3.48E-03 3.34E-02 3.10E 02 Mff-34 3.1tE 03 1.30E 02 1.ffE 92 FE-33 2.71E-82 7.0M 92 9.1FE 02 FE-59 2 35E-94 2.91E-03 3.tTE-03 CD-57 9.TM 83 4.itE 84 3.67E-84 CO-58 I SIE-t! 1.8SE 91 3.37E-t!
CD-60 3.ffE 02 6.22E-02 1.02E-01 ^
n!-65 0.cftfle 1.78C 05 1.7tE-05 H-45 3 2?E 96 2 OfE-44 2.12E-94 00-82 6 3ft 83 2 94E 83 9.3X 95 BR 04 f.45E-06 3.87E te 1.3X-85 Rf 84 2. !M-95 0 00E100 2.13E-05 88-83 7.24E 44 0.tMill 7 24E-04
$R-89 3 OM-45 2 ISE te 2.35E-04 50-90 0.00Ette 4.14E-93 4.14E 03 50 92 1 03E 04 3 57E 04 6 62E 04 T-9? 2 16E-85 0.00Elli 2 96E-05 ZR 95 6 flE-85 3 67E-93 3 13E-03 NS-13 4 TTE.84 6 elt il 7.10E 0?
W-97 6 44E-04 2 86E 03 3 *2E-03 M0-97 13M 94 0.Ittitt 1.3tE-04 IC-f?N 1 llE 04 6.24E 03 1,7M-94 60 103 8 ftEtte 1.t!E-93 1.01E 05
- U 106 f.16t 05 6 4M 04 T.34E-04 AG 10tM 1 lZE 03 5.34E te 1.45E 03 AC-!!0M I 41E 84 7 39E-04 8 tit-04 It?-il5M 1 02E 05 0 00Eift 1.02E 01 50 122 T.16E-05 1.15E 04 1 86E 04 58 124 1 61E 03 3.llE 93 4.Itt 93 50 125 3 3X 93 I IM 92 1 33E-02 IE-131M i StEtte 6 12E-06 6 9M-86 I 131 3 12E 02 1 16E 92 4 89E-02 I-132 2.5tE 04 7 3SE-05 3 24E-04 I 133 1.39E et 3. tat-03 I. Tit 02 I-135 3 IFE-93 1. lM-03 4 29E-43 C5 134 1.61E 03 3 87E-03 4 eM-03 C5 IM 3 14E 06 S.16E te e 2?E-06 C5 137 2 4tE-93 4 47E-03 6 94E 93 LA-lit 6 IX te 1 95E-93 2 36E-03 CE-141 3.45E 04 4 ele-te 4. 94E-01 CE 143 3.37E te 4 stE ef 4.tet 96 CE 144 0 99Ette 1 12E 03 3.lM-83 NP 239 f.t?Ette t FM 03 2 22E-OS M-48 6.3M 91 9 2M 05 1.3rE-t4 28 0S4 3 65E te 0.9 Mitt ~ 3.63E 06 88-07 9 eMt99 4 htE te 4 09E 06 M 131N 1.7M 84 ' t.tMile 1.72E 04 H 1334 4 I M-93 f.3H 64 f. TIE 04 M 133 2 2M 02 1.5M et 3.fM 92 M-131 3.lH-03 i est 93 3.IIE 93
k t
r MCGUIRE LIDUID DOSE- TOTAL 1985 SEMI-ANNUAL NRC SUBMITTAL- TOTAL 68000010 l
l i
! SKIN MAXIMUM DOSE- 6.85D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHNAY- SNORE CO 69 89.16 %
q DONE MAXIMUM DOSE- 4.17D-02 MREM CRITICAL AGE- CHILD CRITICAL PATMMAY- FISH
!!11' it:f*I LIVER MAXIMUM DOSE- 1.24D-91 MREM CRITICAL AGE- CMILD CRITICAL PATHNAY- FISH H 3 41*69 2 CS 134 24.77
- CS 137 30.37 2.
T. BODY MAXIMUM DOSE- 9.46D-82 MREM CRITICAL AGE- ADULT CRITICAL PATMMAY- FISM
- siit! !!lli
! TNYROIB MAXIMUM DOSE- 1.26D-91 MREM CRITICAL AGE- INFANT CRITICAL PATHNAY- DRINKING 1 t N 3 39.61 2 '
I 131 59.86 %
- KIDNEY MAXIMUM DOSE- 7.500-02 MREM CRITICAL AGE- CHILD CRITICAL PATHWAY- DRINKING H 3 68.76 %
1 El11' L2:lii LUNG MAXIMUM DOSE- 4.10D-82 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING 4
H 3 84.50 %
CS 134 5.62 %
CS 137 7.28 % l GI-LLI MAXIMUM DOSE- 1.35D-81 MREM CRITICAL AGE- A DULT CRITICAL PATHNAY- FISH H 3 28.66 % !
CO 58 6.48 %
CO 60 7.17 %
i NB 95 53.48 % !
i
. _ _ __ . __ ___ _ _ . . . . _ _ - _ _ _ . _ . - m_ . _ _ _ _ _ _ .__ _
l l
MCGUIRE LIGUID DOSE- IST STR 1985 SEMI-ANNUAL NRC SUBMITTAL- TOTAL 00000010 SKIN MAXIMUM DOSE- 2.51D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHNAY- SHORE CO 60 98.14 %
DONE MAXIMUM DOSE- 2.29D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH CS 134 30.30 %
CS 137 64.85 % !
LIVER MAXIMUM DOSE- 5.729-92 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING N 3 * %
CS 134 X CS 137 . X T. BODY MAXIMUM DOSE- 4.44D-82 MREM CRITICAL AGE- ADULT CRITICAL PATHNAY- DRINKING H 3 1.02 %
CS 134 4.04 %
CS 137 1.78 %
TNYROIB MAXIMUM DOSE- 8.87D-02 MREM CRITICAL AGE- INFANT CRITICAL PATHNAY- DRINKING H 3 33.05 %
I 131 66.36 %
I KIDNEY MAXIMUM DOSE- 3.91D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHWAY- DRINKING H 3 77.32 %
< CS 134 9.03 %
d CS 137 11.87 %
LUNG MAXIMUM DOSE- 3.37D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 89.52 %
GI-LLI MAXIMUM DOSE- 3.75D'02 MREM CRITICAL AGE- ADULT CRITICAL PATHWAY- DRINKING H 3 60.39 %
CO 54 10.94 %
CO 60 10.81 %
NS 95 14.12 %
I I
MCGUIRE liq"JIP DOSE- 2ND QTR 1985 SEMI-ANNUAL NRC SU5MITTAL- TOTAL 00000010 SKIN MAXIMUM DOSE- 3.45D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHNAY- SHORE CO 68 88.54 %
SOME MAXIMUM DOSE- 3.76D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHWAY- FISH CS 134 30.44 %
CS 137 63.04 %
LIVER MAXIMUM DOSE- 6.54D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH H 3 33.19 %
CS 134 24.53 %
CS 137 34.49 %
T. BODY MAXIMUM DOSE- 5.15D-02 MREM CRITICAL AGE- A DUL T CRITICAL PATHWAY- FISH
$13!
CS 137
$4'$0!
30.03 %
THYROID MAXIMUM DOSE- 3.89D-82 MREM CRITICAL AGE- INFANT CRITICAL PATHWAY- DRINKING H 3 54.46 % .
I 131
~
45.15 %
KIDNEY MAXIMUM DOSE- 3.6 0D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHWAY- DRINKING
' H 3 60.73 %
CS 134 16.20 %
CS 137 20.61 %
LUNG MAXIMUM DOSE- 2.76D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHWAY- DRINKING H 3 79.18 %
CS 134 7.60 %
CS 137 9.71 %
GI-LLI MAXIMUM DOSE- 9.44D-02 MREM CRITICAL AGE- ADULT CRITICAL PATHWAY- FISH H 3 17.34 %
CO 60 5.40 %
NO 95 67.69 %
l
~
E(AulittuttEFFSibi U.1!i !
CA0!0 ACTIVE EFFLUENT PELEASE5 SiATE 08112/85
- 1. LIQUID RELEASES TEta . !?Z UNITS IST OTR 2N3 OTR SUF1074
- 1. CROS5 RA310ACTIV11T j
A. 101AL RELEASE CURIES I cit-01 2.13E-01 3 5?E-01 . 1 3 A"CRACC CONCENTRAT!DN RELEASED UCIfML 3 23E-10 4 0!E-10 3.TCE-12 C. MAXIMUM CONCENTRATION RELEASED Utilt:L 3 E C-01 4.31E 01 t.31E-07 1
- 2. IRIIIUM A. IDIAL RELEASE Cut!ES 1 10E102 f 20E601 2.01E102 B. AVERA&E CONCENTRATION RELEASED UCIIML 2.46E-87 1.75E-0T 2.0TE 07
- 3. 81550LVED NotLE CA5ES A. IMAL RELLASE CURIE 5 1.31E-02 S.47E-03 2.19E 02 B. AVERACE EDXENTRAT!DN RELEASED UC!lML 2.f3!-!! 1.65E-!! 2.24E-11
- 4. CROSS ALPHA ACT!vilf A. 101AL RELEASE CUR!!5 0.00E100 0.00E100 0.00E100 B. AVERACE CONCENTRATION RELEASED UCIfML 0.00Et00 0.00E100 0.00E600
- 5. VOLUME OF LIQU!O WA51E TO 015CHARCE
- CANAL LIIEtl 3.50Et96 3.70E606 7.20E606
- 6. 90LUME OF O!LUTION UATER LITERS 4.46 Ell! 5.26 Ell! 9.72Et!!
- 7. RA810NUCLIDE5 RELEASED CURIES NA-21 4.64E-05 1 !!E-04 1.58E-04 CR 51 1.74E-03 1.6M-02 1.03E-52
!uf-51 1.5?E-03 6.90E-03 8.40E-03 FE-55 1.36E-02 3.5M 02 4.88E 82 FE-59 1.20E-04 1.41E-03 1.3X 03 CO-37 4.BM-43 2.35E-04 2.84E-0 4 E0-58 7.57E-02 9.2SE-02 1.6M 01 CD 68 1. ?M-02 3.11E-92 3. 0M-02 NI-65 0.tMitt I 9M-06 8.90E-06 ZN-65 2.61E-ta 1.tM-84 1.06E 04
, BR-82 3 IM-95 1 47E-05 4.66E 05 BR-84 4.7N 06 1.94E-06 6 66E-05 PS-06 1.06E-03 0 99El08 1.9M 05 R8-89 3 4K-94 8.86Eftf 3. 6M-04 54-09 1.50E 05 1. 0X-44 1.!M 04
, 5R-98 8.stElle 2.07E-OS . 2.07E-05 50-12 S.24E-05 2.79E-04 3 31E-04 T-93 1.4K-05 0.DMitt 1.4M 05 2R-?S 3.91E 05 1.5K-03 1.56E-03 HS-95 2.4K 84 3.30E-93 3.55E-03 NI-97 3.32E 94 1.4K-03 1.T6E-t3 MO-99 6.92E 05 0.00El04 4.92E-05 TC-9?M S.55E-05 3.12E-93 5 67E-05 RU-It3 0.00E100 3.06E-96 3.06E-06 RU-Ile 4 50E-93 3.21E-94 3 6TE-04 AC-100M S.3M-86 2.67E-te B.26E 06 AC-Il0M 7. 0M-95 3.79E-04 , 4. 40E-04 IN-l!5M 5.09E te I.lMt90 0.09E-06
$4-122 3.5M-05 S.74E-05 9.32E-05 58-124 B.44E-44 1.SSE-93 2.4M 03 50-123 1.7M-03 3.00E-03 7.64E-s3 TE-131M 4.09Ette 3.46E-te 3.46E-te 1-131 1.8M-02 3. 0M-03 2.44E 42 1-132 1.25E 04 3.69E-95 1.62E-04 I-133 6.97E-03 1.99E-93 0 96E-03 1 135 1.38E-03 5.6M-it 2.14E-43 C5-134 9. tN-04 1.54E-83 2 34E-03 C5 136 1.37E-06 .2 SM 06 4.15E-96 C5-137 1.2M-93 2.2X-93 3.4X-03 LA-144 3.06E 04 f.74E-94 1.29E 03 CE-141 1.7N-06 2 SM-84 2.02E 04 CE-143 2.!M-96 2.44E 07 3.9K-06 CE-144 0.9MtM 5.59E-04 - S SM-04 NP-239 0.00E600 1.!!E-95 1.llE-05 48 41 3.26E-05 4 61E SS 7.87E 85 RR-SSN t .gM-te 0.00Ettt -
1.8M 96 R8-97 0 00Ette 2.40E 06 2.4tE-06 M-131M O.59E 03
- 9. 0M t90 0.5M-05 IE-133M . 2 96E-95 . 1.15E-04 1 36E-04 IE 133 I laE 92 7.59E-03 g gn-02 H-131 1. 5M-93 1.0!F 03 2 36E-03 l
l l
. ~. . - - - -
MCGUIRE LIGUID DOSE- TOTAL 1985 SEMI-ANNUAL NRC SUBMITTAL- UNIT 1 00000010 SKIM MAXIMUM DOSE- 3.02D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHNAY- SHORE CO 60 49.16 X BONE MAXIMUM DOSE- 3.080-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH
!!111 !!!fti LIVER MAXIMUM DOSE- 4.199-82 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH H 3 54 X 34 41 40 X CS137 CS $40.40 x T. BODY MAXIMUM DOSE- 4.83D-02 MREM CRITICAL AGE- ADULT CRITICAL PATHWAY- FISH H 3 li9.97 X 81117 !2:1! !
THYROID MAXIMUM DOSE- 4.31D-82 MREM CRITICAL AGE- INFANT CRITICAL PATHNAY- DRINKING i
M 3 39 55 %
I 131 59 92 x KIDNEY MAXIMUM DOSE- 3.74D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 68.71 %
CS 134 12.73 x CS 137 16.42 X LUNG MAXIMUM DOSE- 3.04D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 04.47 %
CS 134 5.63 x CS 137 7.29 x GI-LLI MAXIMUM DOSE- 6.74D-02 MREM CRITICAL AGE- A DULT CRITICAL PATHWAY- FISH H 3 28.62 X
, CO 54 6.39 %
CO 60 7.16 %
i Na 95 53.34 x l
i 1
MCGUIRE LIGUID DOSE- IST GTR 1985 SEMI-ANNUAL NRC SUBMITTAL- UNIT I 00000010 SKIN MAXIMUM DOSE- 1.25D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHNAY- SHORE CO 66 90.11 %
SONE MAXIMUM DOSE- 1.14D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHWAY- FISH CS 34 30.24 %
CS 37 64.90 %-
LIVER MAXIMUM DOSE- 2.87D-82 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING
- $ 13 . 9.
CS 137f 24.7 %
T. DODY MRXIMUM DOSE- 2.23D-02 MREM CRITICAL AGE- ADULT CRITICAL PATHNAY- DRIN(ING
~
3 Eilit lg.16%
i:iti THYROID MA%IM96 sTSE- 4.44D-02 MREM CRITICAL AGE- INFANT CRITICAL PATHNAY- DRINKING 2- 33.15 %
.;l 66.26 %
KIPMEY MAXIMUM 00$t- 1.96D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 77.42 %
CS 134 8.98 %
CS 137 11.83 %
LUNG MAXIMUM DOSE- 1.69D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 89.57 %
GI-LLI MAXIMUM DOSE- 1.84D-02 MREM CRITICAL AGE- ADULT CRITICAL PATHWAY- DRINKING H 3 60.69 %
CO 54 10.97 %
CO 60 10.79 %
NB 95 13.81 %
1
~
MCGUIRE LIQUID DOSE- 2ND GTR 1985 SEMI-ANNUAL NRC SUBMITTAL- UNIT 1 00000010 SKIN MAXIMUM DOSE- 1.72D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHNAY- SHORE CO 60 40.54 %
BONE MAXIMUM DOSE- 1.88D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH CS 134 30.44 %
CS 137 63.04 %
LIVER MAXIMUM DOSE- 3.290-82 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH H 3 33.19 %
CS 134 23.53 %
CS 137 34.49 %
T. BODY MAXIMUM DOSE- 2.54D-02 MREM CRITICAL AGE- ADULT CRITICAL PATHNAY- FISH H 3 31 CS 134 34:$2% 0 X CS 137 30.03 %
THYROID MAXIMUM DOSE- 1.95D-02 MREM CRITICAL AGE- INFANT CRITICAL PATHNAY- DRINKING H 3 54.46 %
I 131 45.15 %
KIDNEY MAXIMUM DOSE- 1.80D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY - DRINKING H 3 60.73 %
CS 134 16.20 %
CS 137 20.61 %
LUNG MAXIMUn DOSE- 1.3sD-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 79.14 %
CS 134 7.60 %
CS 137 9.71 %
GI-LLI MAXIMUM DOSE- 4.72D-02 MREM CRITICAL AGE- ADULT CRITICAL PATHNAY- FISH H 3 17.36 %
CO 60 5.80 %
MS 95 67.69 %
I l
J
WPR E WLM G# WO W N UNIT 2 R:010 ACTIVE EFFLUENT RELEA5E5
. DATE . C:112185
- 1. LI:110 RELEASE 5 YEAR . 1755 l UN!il lli OfR 2ND OTR SulI0fAL
- 1. CR055 RAD 10ACTIV!1T A. TOTAL RELEASE CURIE 5 1.44E-01 2.13E-01 3.59E-01
- 8. AVERACE CDNCENTRATION RELEASED UCllML 3.29E-10 4.05E-10 3 70E-10 C. RAIInuM CDNCENTRA!!DN RELEASED UCIfML 3.28E-09 4.31E-09 4.31E 09
- 2. Trit!UM A. TOTAL RELEASE CURIE 5 1.10El02 9.20Ett! 2 O!Et02
- 8. AVERAGE CDNCENTRAi!DN RELEASED UCIINL 2.46E-97 1.75E-07 2.0!E 07
- 3. 81550LVED NOBLE GASES A. ICI AL RELEASE CURIE 5 1.31E-02 8.47E-03 2.18E-02
- 8. AVERACE CDNCENTRATIDN RELEASED UC!lhL 2.93E-11 1.45E-11 2.24E-11
- 4. CR055 ALPMA ACTIVIIT
- 4. 10TAL RELEASE CURIES 9.00[100 0.00Elle 0.00E100 B. ASERACE CDNCENTRATION RELEASED UCIIML 1.00Ette 0.00E100 0.00E100
- 5. SOLUME OF LIGUID WA51E 10 DISCHARGE CANAL LITERS 3 50E106 3.70Ct06 7 20Et06
- 6. t0LUME DF OILUTION ueTER LITERS 4.44E+tl 5.26El!1 9.72Ei!!
- 7. 340!ONUCL10E5 RELEASED CURIES HA-24 4.6tE-05 1.!!E-04 1.50E-04 CR-51 1.74E 03 1.68E-02 1 8:E-02 MN-54 1.StE-03 6.90E-03 8 48E-03 FE-55 1.34E-02 3.53E-02 4.IBE-02 FE-59 1.20E-04 1.41E-93 1.53E-03 CO-57 4.86E-95 2.35E 94 2.04E-94 CD-58 7.57E-02 ? 25E-02 1.4BE-01 CO-48 1.99E-02 3.t!E-82 5.01E-02 NI-65 0.StEtte 8.10E-06 8.90E-06 ZN-65 2.61E-06 1. 03E-04 1.06E-04 SR-82 3.!?C-05 1.47E-05 4 46E-05 00-34 4.72E-04 1.94E-04 4 66E-06 RB-86 1.04E-05 0 00Et00 1 06E-05 El-IB 3.42E-04 0.00Et03 3 42E-04 5R-07 1 50E-05 1 03E-04 1.18E-04 50-98 0.00EIO0 2.07E-05 2.0TE-05 SR-72 5 24E-05 2.7tE-04 3 3tE-04 T-73 1.43E-05 0.00Ellt 1 43E-05 IR-95 3 O!E-05 1.53E-03 1 54E-03 58-95 2.40E-04 3.30E-93 3 55E-03 NS-97 3.32E-04 1. 43E-03 I T4E-03 no-97 6.f2E-05 0.Ittill 4.72E-05 IC-t?M 5.55E-05 3.12E-05 8 67E-05 30-103 0.00Ettl 5 06E-te 5.06E-06 BU-106 4.5DE 85 3 2tE-04 3 67E-04 AG-10BM 5.5?E 04 2.47E-04 8 24E-04 AG-Il0n 7 06E-85 3.70E-04 4 40E-04 IN-It5M 5.Itt-96 0.00E600 5 OtE 06 58-122 3.5BC-95 5 74E-05 9 32E-05 58-124 8.44E-84 1.53E-03 2.40E-03 50-125 1.74E-03 5.00E-03 7 44E-03 TE-131R 0.00E600 3.46E-06 3.46E-04 1-131 1.84E-02 5 10E-03 2.44E-02 1-132 1.25E-94 3. ate-05 1.42E-04 1-133 4.97E-93 1.??E-03 I 96E 93 I-135 1.58E-03 5.40E-04 2.14E-03 C5-134 0. 03E-94 1 $4E-93 2 3*E-03 C5-13A 1.57E 04 2.50E 94 4 ISE-06 C5-137 1.2tE-93 2 23E 03 3 43E-03 L A-let 3.06E-94 f.14E 04 1 2tt-03 CE-14!. 1.72E-04 2.00E-04 2.02E-04 CE-143 2.70E-06 2.44E-07 3 93E 06 CE-144 , 9 StEtte 5.5DE-04 . 5 5tE-04 NP-239 0.00Ette 1.Itt-05 1.11E-05 AR-41 . 3.26E 05 4.41E-05 7.07E-05 sR-ess 1.s2E-06 0.00Ette _'. 1.02E-06 sR-87 0.00Ette 2.49E-96 2 40t-06 IE-131M B.5tE-05 0.00Elle B.53E 05 JE-133M , 2.96E-95 . 1.15E 04 1.3tE-04 IE-133 1.14E-82 7.50E 03 1 GTE-02 NE-175 1.55E 03 1.01E 03 2.56E-03
Mb MCGUIRE LIGUID DOSE- TOTAL 1995 SEMI-ANNUAL NRC SUSMITTAL- UNIT 2 00000010 SKIN MAXIMUM DOSE- 3.02D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHWAY- SHORE CO 60 49.16 %
BONE MAXIMUM DOSE- 3.00D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH CS 134 30.34 %
CS 137 63.74 %
LIVER MAXIMUM DOSE- 4.199-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH H 3 41*54 X CS 134 24.40 %
CS 137 30.40 %.
T. BODY MAXIMUM DOSE- 4.03D-02 MREM CRITICAL AGE- A DULT CRITICAL PATHWAY- FISM N 3 9.97 %
TMYROID MAXIMUM DOSE- '4.31D-82 MREM CRITICAL AGE- INFANT CRITICAL PATHNAY- DRINKING H 3 39.55 %-
I 131 59.92 %
KIDNEY MAXIMUM DOSE- 3.74D-82 MREM CRITICAL AGE- CHILD CRITICAL PATMNAY- DRINKING
' N- 3 60.71 %
e CS 134 12.73 %
CS 137
~
16.42 X 1
LUNG MAXIMUM DOSE- 3.04D-02 MREM CRITICAL AGE- CHILD CRITICAL PATMNAY- DRINKING H 3 04.47 %
CS 134 5.63 %
CS 137 7.29 %
GI-LLI MAXIMUM DOSE- 6.74D-02 MREM CRITICAL AGE- ADULT CRITICAL PATHWAY- FISH H 3 20.62 %
CO 50 6.39 %
' CO 60 7.16 %
I No 95 53.54 %
2
MCGUIRE LIGUID DOSE- IST QTR 1985 SEMI-ANNUAL NRC SUBMITTAL- UNIT 2 00000010 SKIM MAXIMUM DOSE- 1.25D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHNAY- SHORE
] CO 60 90.11 %
DONE MAXIMUM DOSE- 1.14D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH CS 134 30.24 %
CS 137 64.90 %
LIVER MAXIMUM DOSE- 2.87D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING
$$ 3!
C3f37
'hkk 4.77 %
T. DODY MAXIMUM DOSE- 2.23D-82 MREM CRITICAL AGE- ADULT CRITICAL PATHNAY- DRINKING H 3 CS 134 C3 137 3I6%
1: s%
1.74 %
THYROID MAXIMUM DOSE- 4.44D-82 MREM CRITICAL AGE- INFANT CRITICAL PATHNAY- DRINKING H 3 33.15 %
I 131 66.26 %
KIDNEY MAXIMUM DOSE- 1.96D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 77.42 %
CS 134 8.98 %
CS 137 11.43 %
LUNG MAXIMUM DOSE- 1.69D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 89.57 %
GI-LLI MAXIMUM DOSE- 1.88D-02 MREM CRITICAL AGE- A DULT CRITICAL PATHWAY- DRINKING
^
H 3 40.69 %
CD 58 10.97 %
CO 6e 10.79 %
NB 95 13.41 %
i i
MCGUIRE LIQUID DOSE- 2ND QTR 1985 SEMI-ANNUAL NRC SUBMITTAL- UNIT 2 00000010 SKIN MAXIMUM DOSE- 1.72D-03 MREM CRITICAL AGE- TEEN CRITICAL PATHHAY- SHORE CO 60 88.54 %
SONE MAXIMUM DOSE- 1.88D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH CS 134 30.44 %
CS 137 63.08 %
LIVER MAXIMUM DOSE- 3.29D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- FISH H 3 33.19 %
CS 134 28.53 %
CS 137 34.49 %
T. BODY MAXIMUM DOSE- 2.589-02 MREM CRITICAL AGE- . A DULT CRITICAL PATHNAY- FISH H 3 1 CS 34 4'82 30 %
- CS 37 0.03 %
TNTROID MAXIMUM DOSE- 1.95D-02 MREM CRITICAL AGE- INFANT CRITICAL PATHNAY- DRINKING I
H 3 54.46 % ?
I 131 45.15 %
KIDNEY MAXIMUM DOSE- 1.80D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING H 3 60.73 %
CS 134 16.20 %
CS 137 20.61 %
LUNG MAXIMUM DOSE- 1.38D-02 MREM CRITICAL AGE- CHILD CRITICAL PATHNAY- DRINKING N 3 79.18 %
CS I34 7.60 %
CS 137 9.71 %
GI-LLI MAXIMUM DOSE- 4.72D-02 MREM CRITICAL AGE- ADULT CRITICAL PATHHAY- FISH H 3 17.36 %
CO 60 5.80 %
g MS 95 67.69 %
1
MCCUIRE NUCLEAR SIAll00 .
RADIDACTIVE EFFLUENT PELEAiE5 DATE 80112185 II. AIR $0Al'E BELEA5El TEAR 1985 UNIT 5 . !$7 OTR 2ND Oft Sutt01AL 1 TOTAL N00LE GASES CURIE 5 1.31E903 3.89E602 1.70E603
- 2. TOIAL NALOGENS CURIE 5 1.0K 02 2.24E-03 1.30E-02
- 3. TOTAL PARTICULATE G8055 M IA-GannA CURIES 7.56E 94 3.5K 94 1.t!E-03
- 4. 10TAL TA!!!Un Cut!El 1.19E60! 1.66Ett! 2.2 Heft
- 5. TOIAL PARIICULATE Ga055 ALPHA ACilVITY CURIES 0.00Ette 0.00Ette 0.lMite
- 6. MIIMUN NOSLE GA5 N LEA R SATE UCIIMC 1.6tEt03 1.6 Kit 3 1.60Et03
- 7. RA010MUCLIK5 RELEA5EO CURIE 5 PAR 11CULAIES .
CR-51 3.97E-06 4.tK-05 4 5K -95 M-54 3.00E-05 4.21E-05 7.35E-05 CD-53 2.45E-04 6.45E 85 3.10E-04 C3 62 4.05E-05 7.47E-04 4 TM-05 in-af 4.15E 08 5.41E it 9.56E-06 s NS 95 4.34E-10 0.00Etti 4.34E-10 23-103 0.00E400 3.25E Il 3.25E It RU Ite 1.54E-07 0.00Etti 1.54E-07 C5-134 1.54E-94 7.0tE-95 2.24E 04 C5-136 3.45E-09 1.10E-08 1.45E-98 L5-137 2.4M-84 1.25E-04 3.BM-04 CE-It! 1.02E te 3. 9M-19 1.02E 06 CE-144 1.52E-05 7.61E 96 2.2K-05 NALOCEN5 1-13) 6.4?E 03 1.5K-03 7 ffE 03 1-133 4.2fE-03 7.36E-04 5.02E-03 C45E5 E2-855 4.24El0S 6.!M-01 4.16Et00 KOf5 5.34Etti 4 0Kt00 5.93Etti ER-67 4.26E 01 7.10E 02 5.05E-01 ER-89 2.98Et00 3.??E-01 3.36Elit IE-131M 4.08Et03 4.55Ellt 1 l6tet!
'E-13]M 1.75 Ell! 4.lfEttt 2.16E601 11-133 1.17E603 3.66E902 1.5X903 IE-!!5M 1. 0E-03 0.00El00 1.0X 03 IE-tJ5 3.52Ett! 5.17Ettt 6 12E601 AR-41 4.76Et00 1.32Et09 6.0Kt00 00 TOU W15M 10 PRINT THIS RETORT ST UN!!T ITIN)
..r. .
MCGUIRE GAS DOSE- TOTAL 1985 SEMI-ANNUAL NRC SUBMITTAL- TOTAL 00000020 DISPERSION FACTOR- 7.20E-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 M(-2)
BETA AIR DOSE- 4.48E+00 MILLIRADS GAMMA AIR DOSE- 1.79E+00 MILLIRADS T. BODY CRITICAL AGE- CHILD H 3 24.85% CRITICAL PATHWAY- PLUME MAXIMUM DOSE-KR 88 5.15% 1.53D+00 MILLIREM PLUME CONTRIBUTION- 70.99%
XE133 47.00%
XE135 11.56%
AR 41 5.61%
GI-TRACT CRITICAL AGE- CHILD H 3 28,88% CRITICAL PATHWAY- PLUME MAXIMUM DOSE-KR SS 5.16% 1.53D+07 MILLIREM PLUME CONTRIBUTION- 71.07%
XE133 47.85%
XE135 57%
AR 41 11l61%
5 SOME CRITICAL AGE-KR 88 7.21% INFANT CRITICAL PATHWAY- PLUME MAXIMUM DOSE-XE133 65.74% 1.09D+00 MILLIREM PLUME CONTRIBUTION- 99.30%
! XE135 16.17%
AR 41 7.84%
LIVER CRITICAL AGE- CHILD H 3 28.75% CRITICAL PATHWAY- PLUME MAXIMUM DOSE-KR 84 5.14% 1.54D+00 MILLIREM PLWME CONTRIBUTION- 70.74%
XE133 .
46.43%
XE135 11.52%
AR 41 5.59%
KIDNEY CRITICAL AGE- CHILD H 3 28.88% CRITICAL PATHWAY- PLUME MAXIMUM DOSE-KR SS 5.15% 1.53D+00 MILLIREM PLUME CONTRIBUTION- 70.87%,
XE133 46.92%
XE135 11.54%
AR 41 5.60%
THYROID CRITICAL AGE- CHILD N 3 21.82% CRITICAL PATHNAY- PLUME MAXIMUM DOSE-I 131 22.23% 2.02D+00 MILLIREM PLUME CONTRIBUTION- 53.70%'
XE133 35.55%
XE135 4.74%
LUNG CRITICAL AGE- CHILD M 3 28.02% CRITICAL PATHWAY- PLUME MAXIMUM DOSE-KR 88 5.02% 1.58D+00 MILLIREM PLUME CONTRIBUTION- 71.75% i XE133 47.97%
XE135 11.44%
AR 41 5.45%
SKIN CRITICAL AGE- CHILD M 3 12.66% CRITICAL PATHWAY- PLUME MAXIMUM DOSE-KR 85 5 3.49D+00 MILLIREM PLUME CONTRIBUTION- 87.32%
XE133 58'26%
.16%
XE135 13.42%
THYROID AGE- ADULT CRITICAL PATHWAY- PLUME l M 3 16.72% TOTAL DOSE-I 131 16.45% 1.66D+00 MILLIREM PLUME CONTRIBUTION- 65.30%
XE133 43.23%
XE135 10.63%
AR 41 5.16%
THYROID AGE- INFANT CRITICAL PATHWAY- PLUME TOTAL DOSE- 2.02D+00 MILLIREM PLUME CONTRIBUTION- 53.77%
H 3 14.04%
I 131 30.05%
XE135 35.60%
XE135 8.75%
MCGUIRE GAS DOSE- IST QTR 1945 SEMI-ANNUAL SUBMITTAL- TOTAL 00000020 DISPERSION FACTOR- 7.20E-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 MC-2)
SETA AIR DOSE- 3.50E+00 MILLIRADS GAMMA AIR DOSE- 1.42E+00 MILLIRADS T. BODY CRITICAL AGE- CHILD N 3 21.30% CRITICAL PATHWAY- PLUME MAXIMUM DOSE-KR SS 6.31% 1.10D+00 MILLIREM PLUME CONTRIBUTION- 78.54%
XE133 49.71%
XE135 14.49%
AR 41 6.10%
GI-TRACT CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE-H 3 21.32% 1.10D+00 MILLIREM PLUME CONTRIBUTION- 78.62%.
KR ES 6.32%
XE133 49.76%
XE135 14.50% '
AR 41 6.11%
BONE KR as CRITICAL AGE- INFANT CRITICAL PATHNAY- PLUME 7.98% MAXIMUM DOSE- 8.71D-01 MILLIREM PLUME CONTRIBUTION- 99.37%
XE153 62.89%
XE135 18.33%
AR 41 7.72%
LIVER CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME H 3 21.23% MAXIMUM DOSE- 1.11D+00 MILLIREM PLUMk CONTRIBUTION-KR SS 6.29% - 78.27%
XE153 49.54%
XE135 14.44%
AR 41 6.84%
KIDNEY CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME H 3 21.26% MAXIMUM DOSE- 1.10D+00 MILLIREM PLUME CCNTRIBUTION- 78.40%
KR SS 6.30%
XE133 49.62%
XE135 14.46%
AR 41 6.09%
TNTROID CRITICAL AGE- INFANT CRITICAL PATHWAY- PLUME H 3 9.75% MAXIMUP DOSE- 1.55D+00 MILLIREM PL'JME CONTRIBUTION- 55.96%
I 131 31.91%
XE133 35.42%
XE135 10.32%
LUNG CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DOSE-H 3 20.64% 1.14D+00 MILLIREM PLUME CONTRIBUTION- 79.13%
KR SS 6.13%
XE133 50.62%
XE135 14.31%
AR 41 5.91%
SKIN CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME H 3 8.80% MAXIMUM DOSE-KR 85 6.19%
2.67D+00 MILLIREM PLUME CONTRIBUTION- 91.18%
XE133 57.93%
XE135 15.44%
l THYROID AGE- ADULT CRITICAL PATHNAY- PLUME TOTAL DOSE-H 3 11.76% 1.26D+00 MILLIREM PLUME CONTRIBUTION- 68.83%
I 131 17.69%
ER 88 5.53%
XE133 43.56%
IE135 12.70%
AR 41 5.35%
THYROID AGE- INFANT CRITICAL PATHWAY- PLUME TOTAL DOSE-H 3 9.75% 1.55D+00 MILLIREM PLUME CONTRIBUTION- 55.96%
I 131 31.91%
XE135 35.42%
XE135 10.32%
MCGUIRE GAS DOSE- 2ND OTR 1995 SEMI-ANNUAL SUBMITTAL- TOTAL 00000020 BISPER$10N FACTOR- 7.20E-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 M(-2)
BETA AIR DOSE- 9.80E-01 MILLIRADS GAMMA AIR DOSE- 3.71E-01 MILLIRADS T. BODY CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 4.31D-01 MILLIREM PLUME CONTRIBUTION- 51.37%
N 3 48.482 XE133 39.87%
GI-TRACT CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 4.31D-01 MILLIREM PLUME CONTRIBUTION- 51.42%
N 3 44.$3%
XE133 39.91%
CRITICAL AGE- INF4NT CRITICAL PATHNAY* PLUME MAXIMUM DOSE- 2.24D-01 MILLIREM PLUME CONTRIBUTION- 99.01%
X 133 76.45%
XE135 7.70%
AR 41 4.33%
LIVER CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DOSE- 4.33D-01 MILLIREM PLUME CONTRIBUTION- 51.18%
N 3 48.30%
XE133 39.72%
KIM CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DOSE- 4.32D-01 MILLIREM PLUME CONTRIBUTION- 51.30%
N 3 44.41%
XE133 39.82%
TNYROIB CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.22D-01 MILLIREM PLUME CONTRIBUTION- 42.44%
N 3 40.84%
I 131 16.21%
XE133 32.94%
LUNG CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 4.41D-01 MILLIREM PLUME CONTRIBUTION- 52.40%
N 3 47.38%
XE133 40.95%
SKIN CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DOSE- S.25D-01 MILLIREM PLUME CONTRIBUTION- 74.64%
N 3 25.34%
XE133 54.76%
XE135 5.53%
TNYROIB AGE- ADULT CRITICAL PATHNAY- PLUME TOTAL DOSE- 4.09D-01 MILLIREM PLUME CONTRIBUTION- 54.22%
N 3 32.26%
I 131 12.60%
XE133 42.08%
THYROID AGE- INFANT CRITICAL PATHWAY- PLUME TOTAL Dose- 4.76D-01 MILLIREM PLUME CONTRIBUTION- 46.49%
N 3 8.20%
I 131 3.972 XE133 6.04%
i
NCCUIRE NUCLEAR STAi!CN UNIT I RA010ACT!?! EFFLUENT CELEASES j t
DATE - 00112l05
- 11. AttSDRMt. RELLASEl itAR 1995 UlflT5 15T OTR 2 4 OTR $UOTOIAL
'!. TOTAL N00LE CASES CURIE 5 6.5M602 1.95Ef02 0.50E602
- 2. 10TAL HALOCENS CURIES 3.39C 03 1.!!E-03 4.51E-03
- 3. TOTAL PARIICULATE CR055 DETA-CAMMA CURL [5 3.70E 04 1.79E 04 5.57E-04
- 4. TOTAL TR1710M CUR!!5 , 5.9M100 3.30E600 1.12t101
- 5. 10fAL P4ti!Cil4TE GR0il ALPM ACTIf!!T CURIES 0.00(400 0.0M600 0.00Et00
- 6. MIINLt1 NOILE CA5 RELEASE Rett UC!l5EC 1.60tt03 1.60tt03 1.60E603
- 7. RA0!ONUCLIDtl RELEAlt0 CUI!E5 FAtilCULAIES
[4-31 1.90E-H 2.0?t-05 2.27E-05 MN 51 1.5tE 05 2.!M-05 3.6TE-05 CO-50 1.Z3E-04 3.22E 05 1.55E 04 CD-60 2.02[-05 3.74C-06 2.40E-05 5R-07 2.0TE-00 2.71[ 00 4.70E 00 .
N0 95 2.17E-10 0.00tt00 2.17E-10 EU 103 0.0Ht00 1.6X 10 1. 4M-10 RU 106 7.60E-00 0.0!!!00 7.60E-06 C5-134 7.71E-05 3.50E 05 1.12E-04 C5 136 f.72E-07 5.5M-09 7.25E Of C5 137 1.32E-04 6 2N 05 1.98E-04 CE 141 5.1tt-07 1.58E 10 3.1tE-07 CE-144 7.6M-84 3.01t 06 1.14E-05 MALOCEN5 .
1-131 3.24t 03 7 30E 04 3.9?E-03 I 133 2.14t-03 3.60t 04 2. Sit-03 CASE 5 tR 05n 2.12(100 3.09t 01 2.4Hf00 It-05 2.67ttet 3 04400 2 17E401 13 07 2.IN-01 3 ?!E-02 2.5X-01 It 00 1.40ti!0 t 99E 01 1.60t100 IE-131M 3 S 4itt 2.27Ef00 3 31tt00 rC 1339 8 77tt00 2 04Ef00 1.00t101 IE 133 3.0NetC 1.0M t 02 7.66tt02 IE 135M S Itt 04 0 00t100 5 16E 04 IE-135 2.761601 2 90(100 3.06E601 44-41 2.30t400 6.6M-01 3.04E400 t
H T 10 NES PAGE AMI PM 55 RtfuRN51 1
MCGUIRE GAS DesE- TOTAL 1985 SEMI-ANNUAL NRC SUBMITTAL- UNIT 1 00000020 DISPERSION FACTOR- 7.20E-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 MC-2)
BETA AIR DOSE- 2.24E+00 MILLIRADS GAMMA AIR DOSE- 8.96E-01 MILLIRADS T. BODY CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 7.66D-01 MILLIREM PLUME CONTRIBUTION- 70.99%
M 3 28.85%
KR 88 5.15%
XE133 47.00%
XE135 11.56%
AR 41 S.61%
GI-TRACT CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 7.65D-01 MILLIREM PLUME CONTRIBUTION- 71.07%
M 3 28.48%
KR 88 5.16%
XE133 47.05%
XE13 11.57%
AR 4 S.61%
Bene CRITICAL AGE- INFANT CRITICAL PATHNAY- PLUME MAXIMUM DOSE- S.47D-01 MILLIREM PLUME CONTRIBUTION- 99.30%
KR SS 7.21%
XE133 65.74%
XE135 16.17%
AR 41 7.84%
LIVER CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DOSE- 7.68D-01 MILLIREM PLUME CONTRIBUTION- 70.74%
N 3 28,75%
KR 88 5.14%
XE133 46.83%
XE135 11.52%
AR 41 S.59%
KIDNEY CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DOSE- 7.67D-01 MILLIREM PLUME CONTRIBUTION- 70.87%
N 3 28.80%
KR 88 5.15%
XE133 44.92% -
XE135 11.54%
AR 41 S.68%
TMYROID CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 1.01D+00 MILLIREM PLUME CONTRIBUTION- 53.70%
M 3 21.42%
I 131 22.23%
XE133 35.55%
XE135 8.76%
LONG CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DO5E- 7.88D-01 MILLIREM PLUME CONTRIBUTION- 71.75%
N 3 28.02%
KR 88 5.02%
XE133 47.97%
XE135 11.44%
AR 41 S.45%
$ KIN CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 1.74D+00 MILLIREM PLUME CONTRIBUTION- 47.32%
, M 3 12.66%
i KR 85 l S.26%
XE133 58.16%
XE135 13.42% .
i THYRCID AGE- A DULT CRITICAL PATHNAY- PLUME TOTAL DOSE- 8.32D-01 MILLIREM PLUME CONTRIBUTION- 65.30%
N 3 16.72%
I 131 16.45%
XE133 43.23%
XE135 18.63%
AR 41 S.16%
THYROID AGE- INFANT CPITICAL PATHWAY- PLUME TOTAL DOSE- 1.01D+00 MILLIREM PLUME CONTRIBUTION- 53.77%
M 3 14.04%
I 131 30.G5%
XE133 35.60%
XE135 8.75%
MCGUIRE GAS DOSE- IST 4TR 1985 SEMI-ANNUAL SUBMITTAL- UNIT 1 00000020 DISPERSION FACTOR- 7.2eE-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 MC-2)
BETA AIR DOSE- 1.75E+se MILLIRADS GAMMA AIR DOSE- 7.10E-01 MILLIRADS T.50DY CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME H 3 21.38% MAXIMUM DOSE- 5.51D-01 MILLIREM PLUME CONTRIBUTION- 78.54%
KR 88 6.31%
XE133 49.71%
XE135 14.49%
AR 41 6.10%
GI-TRACT CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.50D-01 MILLIREM PLUME CONTRIBUTION- 78.62%
M 3 21.32%
KR 88 6.32%
XE133 49.76%
XE135 14 0%
AR 41 6. 1%
BONE CRITICAL AGE- INFANT CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 4.35D-01 MILLIREM PLUME CONTRIBUTION- 99.37%
KR 88 7.98%
XE133 62.89%
XE135 18.33%
AR 41 7.72%
LIVER CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.53D-01 MILLIREM PLUME CONTRIBUTION- 78.27%
M 3 21.23%
KR 88 6.29%
XE133 49.54%
XE135 14.44%
AR 41 6.08%
KIDNEY CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.52D-01 MILLIREM PLUME CONTRIBUTION- 78.40%
H 3 21.26%
KR 88 6.30%
XE133 49.62%
XE135 14.46%
AR 41 6.09%
THYROID CRITICAL AGE- IhFANT CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 7.73D-01 MILLIREM PLUME CONTRIBUTION- 55.96%
H 3 9.75%
I 131 31.91%
XE135 35.42%
XE135 18.32%
l LUNG CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.69D-01 MILLIREM PLUME CONTRIBUTION- 79.13%
H 3 20.64%
KR 88 6.13%
XE133 58.62%
XE135 14.31%
AR 41 5.91%
SKIN CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 1.33D+00 MILLIREM PLUME CONTRIBUTION- 91.18%
i
' M 3 8.40%
KR 85 6.19%
XE133 57.93%
XE135 g 15.84%
THYROID AGE- ADULT CRITICAL PATHWAY- PLUME TOTAL DOSE- 6.29D-01 MILLIREM PLUME CONTRIBUTION- 68.83%
H 3 11.76%
I 131 17.69%
KR 88 5.53%
XE133 43.56%
XE135 12.70%
AR 41 5.35%
THYROID AGE- INFANT CRITICAL PATHWAY- PLUME TOTAL DOSE- 7.73D-01 MILLIREM PLUME CONTRIBUTION- 55.96%
H 3 9.75%
1 131 31.91%
XE135 35.42%
i XE135 10.32%
MCGUIRE GAS DOSE- 2ND STR 1985 SEMI-ANNUAL SUBMITTAL- UNIT 1 00000020 DISPERSION FACTOR- 7.20E-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 MC-2)
BETA AIR DOSE- 4.90E-01 MILLIRADS CAMMA AIR DOSE- 1.85E-01 MILLIRADS T. BODY CRITICAL AGE- CHILD H 3 4a.44% CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 2.16D-01 MILLIREM PLUME CONTRIBUTION- 51.37%
XE133 39.37%
GI-TRACT CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME M
XE135 3 4a.53% MAXIMUM DOSE- 2.15D-01 MILLIREM PL'!dE CONTRIBUTION- 51.42%
39.912 BONE CRITICAL AGE- INFANT CRITICAL PATHWAY- PLUME' XE133 76.45% MAXIMUM DOSE- 1.12D-01 MILLIREM PLUME CONTRIBUTION- 99.01%
XE135 7.70%
AR 41 0.33%
LIVER CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME N 3 48.30% *t MAXIMUM DOSE- 2.16D-01 MILLIREM PLUME CONTRIBUTION- 51.17%
XE133 39.72%
KIDNEY CRITICAL AGE- CNILD CRITICAL PATHNAY- PLUME M 3 48.41% --
MAXIMUM DOSE- 2.16D-01 MILLIREM PLUME CONTRIBUTION- 51.30%
XE133 39.52%
TNYROID CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME M 3 40.46 % MAXIMUM DOSE- 2.61D-01 MILLIREM PLUME CONTRIBUTION- 42.44%
I 131 16.21%
XE133 32.94%
LUNG CRITICAL AGE- CHILD !
N CRITICAL PATHWAY- PLUME MAXIMUM DOSE-XE133 3 47.38% 2.21D-01 MILLIREM PLUME CONTRIBUTION- 52.40%
48.95%
. SKIN CRITICAL. AGE- CHILD CRITICAL PATHWAY- PLUME H 3 25.34% MAXIMUM DOSE- 4.12D-01 MILLIREM PLUME CONTRIBUTION- 74.64%
IE133 54.76%
XE135 5.53%
TNYROID AGE- ADULT CRITICAL PATHWAY- PLUME H 3 32.24% TOTAL DOSE- 2.04D-01 MILLIREM PLUME CONTRIBUTION- 54.22%
I 131 12.60%
i XE133 42.es%
TNYROID AGE- INFANT CRITICAL PATHWAY- PLUME M 3 28.20% TOTAL DOSE- 2.34D-01 MILLIREM PLUME CONTRIBUTION- 46.49%
I 131 23.97%
XE133 36.08%
MCCU1RE NUCLEAR 51Ai!0F
- UNIT 2 RA010 ACTIVE EFFLUENT RCLEASE5 .
CITE CL/12It3
!!. AIRC3RNE RELEASES TEAR tea $
UNIT 5 157 OTR 2ND OTR 5ttiofAL 1 10TAL NOBLE GA5ES CUAIE5 6.55 Eft 2 1.95 Ell 2 0 5tEll2
- 2. 1014L NALDGENS cue!El 5 3tE-03 1.12E-03 6.51E-03
- 3. IDTAL PAAi!CULATE G8055 OETA-Ganna CURIE 5 3.70E-04 1.79E-04 5.5FE-04
- 4. 10iAL IAITItM CURIE 5 1.95E400 3.3fEt04 1.12Et01 5 1014L PAATICULATE GB055 AltNA ACI191TT CURIE 5 8.90Ette 0.StEtte f.etttle
- 6. NAt! Nun NG3LE GA5 RELEASE RAIE UCll5EC 1.40Ett3 1.4tElt3 1.6tE603 7 RA010HUCLIBE5 RELEASED CUAIES PARIICULATE5 La-51 1.?tt-86 2 07E 05 2.2tE 05 MM-51 1.54E-05 2.13E-05 3.67E-05 CO 50 1.23E 84 3.22E 05 1.55E te CD el 2.92E-05 3 74E-f6 2 4tE-05 5a-89 2.OTE-te 2.7tt-et 4.7tt te NO-75 2.17E-19 0.00E100 2.17E 10 20 143 0.00Eltt 1.63E-10 1.43E-10 RU It6 7 6tE-te e ffEllt 7.40E-te C5-134 7.71E t3 3.5tE-95 1.12E 94
~
C5-136 1.7 E-07 5.52E it 7.25E-t?
L5-137 1.32E-04 6.23E 05 1.tst-84 CE 141 5 IIE Of 1.54E-10 5.!!E 07 CE 144 7.6tE 06 3.01E-04 1.14E-05 f!ALOCEn5 I 131 3.241-03 7.!tt 04 3.99E-03 I-133 2.14E-f3 3.6tE-04 2.51E 03 G45E5 tr-85n 2.12 Eft 3 3.lfE 01 2.43Ellt 12 35 2.47E601 3.04E400 2.tFEtti 12 37 2.13E C1 3.?!E-8 2.53E li 12 99 1.43 Elta 1.ttt il I.69E+09 XE-131n 3.04Elte 2 27Ettt 5.31E+00 IE-13M 0.77Ettt 2.44Efte 1.09Elft AI-133 5.83 Eft 2 1.03 Ell 2 7.64 Eft 2 1E-1353 5.lfE-94 9.etEfft 3.16E-84
- E-135 2.76Elt! 2.tttill 3.06Etti At 41 2.33EfSO 6.6ft 01 3.04Et00 4
le fee Wish is Run Another ProgeseflTIN!:
S
RCGUIRE GAS DOSE- TOTAL 1985 SEMI-ANNUAL NRC SUMMITTAL- UNIT 2 00000020 BESPERSION FACTOR- 7.20E-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 MC-2)
BETA AIR DOSE- 2.24E+00 MILLIRADa GAMMA AIR DOSE- 8.96E-01 MILLIRACS T. BODY CRITICAL AGE- CHILD CRITICAL PATHWAY- PLOME MAXIMUM DOSE- 7.66D-01 MILLIREM PLUME CONTRIBUTION- 70.99%
N 3 28.85%
KK SS S.15%
XE133 47.80%
XE135 11.56%
AR 41 5.61%
SI-TRACT CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME M 3 28.84% MAXIMUM DOSE- 7.65D-C1 MILLIREM PLUME CONTRIBUTION- 71.07%
ER 88 5.16%
XE133 47.05%
XE135 11.57%
AR 41 5.61%
ME CRITICAL AGE- INFANT CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.47D-01 MILLIREM PLUME CONTRIBUTION- 99.30%
KR 48 7.21%
XE133 45.74%
Xf135 16.17%
AR 41 7.84%
LIVER CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME '
N 3 24.75% MAXIMUM DOSE- 7.64D-01 MILLIREH PLUME CONTRIBUTION- 70.74%
ER SS 5.14%
XE133 44.83%
XE135 11*52%
AR 41 5 59%
RIM CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 7.47D-01 MILLIREM PLUME CONTRIBUTION- 70.87%
M 3 24.40%
ER SS 5.15%
XE133 46.92%
XE135 11.54%
AR 41 5.60%
TMYROID CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 1.01D+00 MILLIREM PLUME CONTRIBUTION- 53.70%
N 3 21.42%
I 131 22.23%
XE133 35.55%
XE135 8.74%
LUNG CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 7.88D-01 MILLIREM PLUME CONTRIBUTION- 71.75%
N 3 28.02%
ER 84 5.92%
XE133 47.97%
XE135 11.44% .
AR 41 5.45%
SAIN CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 1.74D+00 MILLIREM PLUME CONTRIBUTION- 87.32%
N 3 12.66%
ER 85 $.26%
XE133 g 8.16%
XE135 3.42%
TMYROID AGE- ADULT CRITICAL PATHWAY- PLUME TOTAL DOSE- 8.32D-01 MILLIREM PLUME CONTRISUTION- 65.30%
M 3 16.72%
I 131 16.45%
IE133 43.23%
IE135 10.63%
AR 41 5.16%
THYROID AGE- INFANT CRITICAL PATHWAY- PLUME TOTAL DOSE- 1.01D+00 MILLIREM PLUME CONTRIBUTION- 53.77%
N 3 14.04%
I 131 30.05% .
XE135 35.60%
%E135 8.75%
MCGUIRE GAS DOSE- IST QTR 1985 SEMI-ANNUAL SUBMITTAL- UNIT 2 00000020 BISPER$10N FACTOR- 7.20E-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 MC-2)
BETA AIR DOSE- 1.75E+80 MILLIRADS GAMMA AIR DOSE- 7.10E-01 MILLIRADS T. BODY CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.51D-01 MILLIREM PLUME CONTRIBUTION- 78.54%
N 3 21.30%
ER SS 6.31%
XE133 49.71%
XE135 14.49%
AR 41 6.10%
GI-TRACT CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.500-01 MILLINEM PLUME CONTRIBUTIDN- 78.62%
M 3 21.32%
ER SS 6.32%
XE133 49.76%
XE135 14.50%
AR 41 6.11%
SONE GITICAL AGE- INFANT CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 4.35D-01 MILLIREM PLUME CONTRIBUTION- 99.37%
XE133 62.89%
XE135 18.33%
AR 41 7.72%
LIVER CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.53D-01 MILLIREM PLUME CONTRIBUTION- 78.27%
N 3 21.23%
KR 88 6.29%
XE133 49.54%
XE13S 14.44%
AR 41 6.84%
RIDNEY CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 5.52D-01 MILLIREM PLUME CONTRIBUTION- 78.40% .
M 3 21.26%
ER as 6.30%
XE133 49.62%
XE135 14.46%
AR 41 6.09% -
TMYROID CRITICAL AGE- INFANT CRITICAL PATHWAY- PLUME MAXIMUM DOSE- 7.73D-01 MILLIREM PLUME CONTRIBUTION- 55.96%
N 3 9.75%
I 131 31.91%
XE133 35.42%
XE135 18.3Z%
LUNG CRITICA. AGE- CHILL C41 TIC L PATHWAY- PLUME MAXIMUM DOSE- 5.69D-01 MILLIREM PLUME CONTRIBUTION- 79.13%
M 3 28.64%
KR SS 6.13%
XE133 58.62:
XE135 14.31%
AR 41 5.91%
SRIN CRITICAL AGE- CHILD CRITICAL PATHWAY- PLUME MAXIMUM Do,SE- 1.33D+00 MILLIREM PLUME CONTRIBUTION- 91.18%
n 3 a.Se%
KR SS 6.19%
XE133 g *7.93%
15.44%
XE135 TNYROID AGE- ADULT CRITICAL PATHWAY- PLUME TOTIAL DOSE- 6.29D-01 MILLIREM PLUME CONTRIBUTION- 68.83%
M 3 11.76%
I 131 17.6J%
KR 88 5.53%
XE133 43.56%
XE135 12.70%
AR 41 5.35%
THYROID AGE- INFANT CRITICAL PATHWAY- PLUME TOTAL DOSE- 7.73D-01 MILLIREM PLUME CONTRIBUTION- 55.96%
M 3 9.75%
I 131 31.91%
XE135 35.42%
XE135 10.32%
MCGUIRE GAS DOSE- 2ND STR 1945 SEMI-ANNUAL SUOMITTAL- UNIT 2 00000020 DISPERSION FACTOR- 7.2eE-05 SEC/CU-M DEPOSITION FACTOR- 2.30E-09 M(-2)
BETA AIR DOSE- 4.9eE-01 MILLIRADS GAMMA AIR DOSE- 1.85E-el MILLIRADS T.BSDY CRITICAL AGE- CHILD CRITICAL PATMMAY- PLUME N 3 44.44% MAXIMUM DOSE- 2.16D-el MILLIREM PLUME CONTRIBUTION- 51.37%
XE133 39.87%
GI-TRACT CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME N 3 44.53x MAXIMUM DOSE- 2.15D-01 MILLIREM PLUME CONTRIBUTION- 51.42%
XE133 39.91X X
X 13s
! CRITICAL AGE-7I:$Stsx INFANT CRITICAL PATHNAY- PLUME MAXIMUM DOSE- 1.12D-01 MILLIREM PLUME CONTRIBUTION- 99.01%
AR 41 a.33x LIVER CRITICAL AGE- CMILD ' CRITICAL PATHNAY- PLUME N 3 44.302 MAXIMUM DOSE- 2.16D-01 MILLIREM PLUME CONTRIBUTION- 51.17%
XE133 39.72X KIDNEY CRITICAL AGE- CHILD CRITICAL PATMMAY- PLUME MAXIMUM DOSE- 2.16D-01 MILLIREM PLUME CONTRIBUTION- 51.38%i N 3 4e.4 x XE133 39.822 CHILD
- CRITICAL PATMMAY- PLUME CR MAXIMUM DOSE- 2.61D-01 MILLIREM PLUME CONTRIBUTION-TNYROID N x 40..I.TICAL AGE- 42.44%-
I 131 16.21%
XE133 32.94X LUNG CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DOSE- 2.21D-01 MILLIREM PLUME CONTRIBUTION- 52.40%
M 3 47.34%
XE133 4e.95X SKIN CRITICAL AGE- CHILD CRITICAL PATHNAY- PLUME MAXIMUM DOSE- 4.12D-01 MILLIREM PLUME CONTRIBUTION- 74.64%-
Xk13! 135
!!:Mi S.53X TNYROID AGE- ADULT CRITICAL PATMNAY- PLUME TOTAL DOSE- 2.e4D-el MILLIREM PLUME CONTRIBUTION- 54.22%
N 3 32.24%
I 131 12.68%
XE133 42.84%
THYROID AGE- INFANT CRITICAL PATMMAY- PLUME TOTAL DOSE- 2.38D-01 MILLIREM PLUME CONTRIBUTION- 46.49%
H 3 20.20%
I 131 23.97%
XE133 36.04%
i i l
l l
1
MCGUIRE NUCLEAR STATION The estimated percentage of error for both Liquid and Gaseous
' effluent release data at McGuire Nuclear Station has been determined to be +234. This number was derived by summing the following individLal estimates of errors:
- 1) Flow rate determining devices = 1 56
- 2) Counting error = +154
. 3) Sample preparation error =
t 34 9
i O
JMS/pja.002 l
l I
i
l 1
I i
MCGUIRE NUCl. EAR STATION 1
j SOLID RADIDACTIVE WASTE SHIPPED TO A DISPOSAL FACILITY REPORT PERIOD 1-01-85 Tim 0 UGH 6-30-85 l
i j
NupSER OF Mup5ER OF ndASTE CONT. BlSIAL 10LLSE TOTAL ACT. EST. TOTAL TYPES OF WASTE SMIPPED SHIPfENTS CONTAINERS CLASS TYPE (fts) (m') Cl ERROR 1 1 tsASTE Fa0N LIQUID SYSTEsts (A) Deustered Pouses Restas 8 8 SA LSA 1.600 45.31 7.85E-2 10 LB) Demetered Seed Restas 3 3 2A lB LSA 585 16.57 101.253 to (C) Evaporator Concentrates 9 9 N/A N/A 9 3 p N/A 4
(D) Demetered Mecheatcel Filters 3 29 29A LSA 231.1 6.54 13.275 15 (E) Demetered Dominereltzers 1 3 3A LSA 198 5.61 3.33 10
) 2 ORY SOLID leh5TE j
j (A) Dry Active Ideste (compacted) 9 99 994 LSA 9.10B 257.94 1.856 IS (B) Dry Active Weste (non-cewected) 9 19 19A LSA 1.748 49.50 5.424E-1 15 l
(C) Irradiated Camponents p p N/A N/A 3 p g N/A l
i TOTALS 22 161 1604 la ---
13.470.1 381.49 120.335 ---
e i
i l
i 1
i . _ _ _ _ . _-
S-ry of Nejor Radteauc!!de Campeetties (Contiemed)
Suasary of IInjer Radienectade Campeasties Radiomettide 1 Abundance (C) Eveperater Caecentretes (eems ehtpped this period) hoe of tiestee
, (D) Bewatered leecheetcel Filtere 3-3 0.33
- 3. tametee free Li p ad Systeme I I*"
Ile-54 2.78 (4) Beestored Poudes Bestee C-14 58.7 10.54 u-3 15.0 fe-59 0.54 Fe-55 32.4 3.02 Co-137 0.8 32.H a
Co-834 e.7 h-M 0.M M 0.3 2r-95 e.it Pu-241 0.12 (t) Boostered Beed Bestes Ihn-54 2.6 ***3 Co-57 0.18 " ' **'
h-M 42.61 Bl'4} 4*II Co-68 21.44 (E) Bewetered Boeimeralisere Co-60 18.4
~
Co-134 4.88 N**
Co-837 4.03 2.4 5-3 0.25 e- 5.6 Fe-55 6.M Co-837 8.6 Ni-63 18.17 .2 C-14 <.01 *~ $'
pe.241 4.01 I"
. 2. Dry So!!d timete ITRU <.01 q g, (4) Dry active Weste Cr-SI 4.26 (campacted in ese-compacted) 8te-54 2.96 Co-54 55.20 Co-6e 86.08 h-95 4.59 Zr-95 2.35 Pu-241 0.76
- everage 1 h - e for o!! ekspesete C-16 0.44 Fe-55 II.64 N1-63 8.68 (S) Irredaeted Campeeente (some shippped thae period)
8 i DUKE POWEn COMPANY P.O. Box 33180 CHARLOTTE N.C. 98942 HAL B. T1*cKER retrenown vics reassment (704)373-45'll smasa ; _ ;-
August 30, 1985 Dr. J. Nelson Grace, Regional Administrator .
U. S. Nuclear Regulatory Commission ..
Regioe. II .1 101 Marietta Street, NW, Suite 2900 "
Aclanta, Georgia 30323 y
~
Subject:
McGuireNuclearStationO Docket Nos. 5&369/370 ro Semi-Annual Radioactive Effluent Release Report -
Pursuant to McGuire Technical Specification 6.9.1.7, attached is the Subject Report for the period of January, 1985 to June 1985.
As a result of radiation releases from McGuire Nuclear Station, no member of the public received an annual calculated dose exceeding those set forth in 40 CFR Part 190. This determination was made considering that there.are no other fuel cycle facilities nearby which would significantly increase the dose to any member of the public.
The Semi-Annual Effluent Release Report for the second half of 1984 (trans-mitted by letter of March 1, 1985) indicated that the McGuire Units 1 and 2 Ventilation Unit Condensate Drain Tank composite samplers were expected to be replaced and operable by July, 1985. Due to additional commitments, design and installation of the composite samplers was not possible. Current design projections indicate that this will be implemented during the fourth quarter of 1986, with completion by December 31, 1986.
Very truly yours, Hal B. Tucker l$
SAG /hrp Attachments cci Mr. Harold R. Denton, Director Mr. W. T. Orders Office of Nuclear Reactor Regulation NRC Resident Inspector U. S. Nuclear Regulatory Commission McGuire Nuclear Station Washington, D. C. 20555 _.
DESI ATED ORIGINAL Certified 37 ;({,[g g O beat TO M A,54o 6c e At on IEE 8!
,